Fundz

Chomix Biotech Announces Millions Of Dollars Series Pre-A+ Financing To Accelerate The Development Of Chemoproteomics Platform

PRIVATEMay 15, 2023

Round Type

Funding Round

NanjingBiotechnology

Investors

Morning Spring VentureTsinghua Innovation VenturesTiger Yeah Capital

Description

Recently, ChomiX Biotech Co., Ltd. (hereinafter referred to as ChomiX), a leading biotechnology company focusing on the preclinical development of innovative small molecule drugs, announced the completion of millions of dollars Pre-A+ Financing by TigerYeah Capital,old shareholder Tsinghua Innovation Ventures, and Morning Spring Venture. The proceeds will be used to further develop ChomiX's chemoproteomics platforms, expand covalent compound libraries, and initiate several screening projects against traditionally undruggable targets.

Quick answer

ChomiX raised an undisclosed amount in a Funding Round round, dated May 15, 2023. Investors: Morning Spring Venture, Tsinghua Innovation Ventures and Tiger Yeah Capital. ChomiX is based in Nanjing, Jiangsu, China.

How much did ChomiX raise?
ChomiX raised an undisclosed amount in a Funding Round round on May 15, 2023.
Who invested in ChomiX?
Morning Spring Venture, Tsinghua Innovation Ventures and Tiger Yeah Capital are named as investors in this round.
What does ChomiX do?
ChomiX Biotech Co., Ltd. is a leading biotechnology company focusing on the preclinical development of innovative small molecule drugs.
Where is ChomiX based and how big is it?
ChomiX is based in Nanjing, Jiangsu, China.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as ChomiX that raised within 45 days of this round, from Fundz verified event records.

  • CytomX Therapeutics, Inc. raised $30M on June 29, 2023.
  • CurvaFix raised $24M on June 29, 2023.
  • TearClear Corp. raised $12M on June 29, 2023.
  • Evommune raised an undisclosed amount (Series B) on June 28, 2023.
  • Gleamer SAS raised $30M (Funding Round) on June 28, 2023.
  • RiboPro raised an undisclosed amount (Funding Round) on June 28, 2023.

Who to call at ChomiX, and when

A new round usually means ChomiX is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ChomiX raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ChomiX, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ChomiX. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ChomiX

Location

Nanjing, Jiangsu, China

About

ChomiX Biotech Co., Ltd. is a leading biotechnology company focusing on the preclinical development of innovative small molecule drugs. With chemoproteomics as the core technology, ChomiX is engaged in the discovery of novel lead compounds and protein targets in living cells. Officially operated in 2021, ChomiX has established multiple intersecting platforms, including chemical biology, bioinformatics, medicinal chemistry, molecular and cell biology, etc. Now ChomiX has been authorized numbers of chemoproteomics related patents and built a laboratory with a variety of advanced instruments. ChomiX has partnered with many innovative small molecule drug R&D companies, including PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725), and hundreds of research institutes. ChomiX is committed to quickly breaking through the barriers of undruggable targets and accelerating the discovery of innovative small molecule drugs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ChomiX raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ChomiX's next move

See what Strategic adds

ChomiX raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.